The News Bureau, UPI, calls the Cannabis Boom a “New Economy”  
Cannalink, Inc. (CNLK) is well positioned to become a major Player in the Medical
and Therapeutic Cannabis Industry, by providing essential Products and Services
to both Consumers and Businesses in the MJ Space



The high level of excitement that accompanies the “Cannabis Rush” has given rise to a fractured industry still littered with unsophisticated and inexperienced entrepreneurs. However, underneath this noise, a handful of leading edge and well run companies are beginning to emerge and Cannalink believes that tremendous potential exists. Cannalink’s experienced management team will be able take advantage of the fractured market by executing swiftly on the Company’s strategic focus.



Develop, manufacture and/or acquire high quality CBD-based products that are professionally 
delivered in the most efficient manner practicable (i.e.sublingually).


Professionally merchandise, market and distribute its products through its existing 
Healthcare Practitioner Network. 


 Acquire Companies and/or enter into strategic alliances that have a synergistic business model,
are a strategic fit, and will accelerate revenue development for CLNK.


Provide investment and merchant banking services for emerging companies
in the MMJ space.



CNLK plans to take advantage of the current ongoing consolidation trend in a scattered market with many small and inexperienced organizations along with the willingness of smaller companies to strategically align and/or seek professional advice and utilize reliable managerial and financing sources. Cannalink is in an ideal position to provide all these services.

CNLK has a strong and diversified management team with long standing experience and relationships in the cannabis and financial industries. Management has a clear four-prong Four-Year-Plan that is ideally suited to take advantage of this fast growing and still fragmented market. CNLK will precisely execute its business plan, quickly identify new and profitable investment opportunities and surpass performance of the fragmented competition to produce significant returns for its investors.

The Company’s current focus is on aggressively expanding its current product roster, add to its current management team and expand its existing distribution network of health practitioners. The Company is in the process of intensifying its ongoing discussions for strategic alliances and potential acquisitions through its merchant banking services, which should generate a significant portion of its future revenues, especially during FY2 through FY3

The Company has been trading publicly under the symbol CNLK (OTC Pink Sheets) since September 9, 2014 and intends to become fully-reporting within nine (9) to twelve (12) months. In the interim, CNLK plans to commence with filing financial reports with OTC Markets in order to comply with reporting obligations necessary to make the benefits of Rule 144 available to its shareholders.





Through its CannaVentures division, the Company will provide Investment and Merchant Banking services to emerging companies in the industrial hemp and medical marijuana space. Although there are a large number of entrepreneurial participants in the infant MMJ industry, many of these players operate through companies that lack operating and financial capabilities.

 Cannalink will provide guidance to emerging companies by offering business consulting and investment banking services and, when appropriate, will invest, acquire and/or joint venture with those MMJ opportunities that it finds particularly attractive




 Profit Opportunity 2



Cannalink maintains its headquarters in San Diego and is managed by its CEO and Chairman, Robert L. Plomgren together with its Chief Financial Officer, Robert Malasek. The team is supported by a two-member Advisory Board with extensive epxerience in the MJ market and the financial industry. Additional key positions will be filled with experienced managers within the next 6 months.


Team 1



Download Blue

 And if you prefer, you can talk to REAL people.
They will answer you questions.







StockWatchIndex makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in the publications for its Stock Watch List and the information is not to be construed as personal financial advice. Some information has been generated by reliable third party entities, but has not been checked for accuracy by Stock watch Index. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein.


StockWatchIndex is not responsible for any error which may be occasioned at the time of publishing of the information in its Stock Watch List or any error, mistake or shortcoming. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of this document. StockWatchIndex expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. StockWatchIndex does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.